These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 35279104

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Exosome-related lncRNA score: A value-based individual treatment strategy for predicting the response to immunotherapy in clear cell renal cell carcinoma.
    Yang Z, Zhang X, Zhan N, Lin L, Zhang J, Peng L, Qiu T, Luo Y, Liu C, Pan C, Hu J, Ye Y, Jiang Z, Liu X, Sun M, Zhang Y.
    Cancer Med; 2024 Jun; 13(11):e7308. PubMed ID: 38808948
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Construction of a 12-Gene Prognostic Risk Model and Tumor Immune Microenvironment Analysis Based on the Clear Cell Renal Cell Carcinoma Model.
    Wang S, Yu Z, Cao Y, Du P, Ma J, Ji Y, Yang X, Zhao Q, Hong B, Yang Y, Hai Y, Li J, Mao Y, Wu S.
    Cancer Control; 2024 Jun; 31():10732748241272713. PubMed ID: 39115042
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Bioinformatics profiling integrating a four immune-related long non-coding RNAs signature as a prognostic model for papillary renal cell carcinoma.
    Liu Y, Gou X, Wei Z, Yu H, Zhou X, Li X.
    Aging (Albany NY); 2020 Jul 27; 12(15):15359-15373. PubMed ID: 32716909
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.
    Fritz HKM, Lindgren D, Ljungberg B, Axelson H, Dahlbäck B.
    Eur J Cancer; 2014 Jul 27; 50(10):1758-1765. PubMed ID: 24793999
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The impact of TNFSF14 on prognosis and immune microenvironment in clear cell renal cell carcinoma.
    Xu F, Guan Y, Zhang P, Xue L, Yang X, Gao K, Chong T.
    Genes Genomics; 2020 Sep 27; 42(9):1055-1066. PubMed ID: 32725578
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A promising Prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genes.
    Cao P, Wu JY, Zhang JD, Sun ZJ, Zheng X, Yu BZ, Cao HY, Zhang FL, Gao ZH, Wang W.
    BMC Cancer; 2022 Jun 23; 22(1):691. PubMed ID: 35739510
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study.
    Sanchez A, Furberg H, Kuo F, Vuong L, Ged Y, Patil S, Ostrovnaya I, Petruzella S, Reising A, Patel P, Mano R, Coleman J, Russo P, Liu CH, Dannenberg AJ, Chan TA, Motzer R, Voss MH, Hakimi AA.
    Lancet Oncol; 2020 Feb 23; 21(2):283-293. PubMed ID: 31870811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.